- Home
- CGEN
CGEN
Compugen Ltd.
as 11-15-2024 4:00pm EST
| Founded: | 1993 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2000 |
| Target Price: | $4.00 | AVG Volume (30 days): | 277.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.61 - $3.03 | Next Earning Date: | 11-12-2024 |
| Revenue: | $59,852,000 | Revenue Growth: | 698.03% |
| Revenue Growth (this year): | 18.69% | Revenue Growth (next year): | -29.22% |
Latest Compugen Ltd. News
CGEN Breaking Stock News: Dive into CGEN Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
GuruFocus.com
5 days ago
Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ...
Zacks
5 days ago
Compugen (CGEN) Q3 Earnings and Revenues Lag Estimates
Associated Press Finance
5 days ago
Compugen: Q3 Earnings Snapshot
PR Newswire
6 days ago
Compugen Reports Third Quarter 2024 Results
PR Newswire
7 days ago
Compugen to Participate in Stifel 2024 Healthcare Conference
PR Newswire
12 days ago
Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024
PR Newswire
20 days ago
Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Compare CGEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CGEN Compugen Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.